Solar Enertech Corp - Quarterly Report (10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended June 30, 2008

	OR

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from ________________ to _________________

Commission File Number 333-120926

SOLAR ENERTECH CORP.

(Exact name of registrant as specified in its charter)

Delaware		98-0434357
State or other jurisdiction of		(I.R.S. Employer
incorporation or organization		Identification No.)

1600 Adams Drive

Menlo Park, CA 94025

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (650) 688-5800

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes R No £

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

	Large accelerated filer	o		Accelerated Filer o
	Non-accelerated filer	o		Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Number of shares outstanding of registrant’s class of common stock as of August 1, 2008: 111,906,710

Table of Contents

SOLAR ENERTECH CORP

FORM 10-Q

I NDEX

		PAGE
	Part I. Financial Information
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets - June 30, 2008 and September 30, 2007	3
	Unaudited Condensed Consolidated Statements of Operations – Three and Nine Months Ended June 30, 2008 and June 30, 2007	4
	Unaudited Condensed Consolidated Statements of Cash Flows – Nine Months Ended June 30, 2008 and June 30, 2007	5
	Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3.	Quantitative and Qualitative Disclosures about Market Risks	25
Item 4.	Controls and Procedures	25
Item 4T.	Controls and Procedures	26
	Part II. Other Information
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sale of Equity Securities and Use of Proceeds	27
Item 3.	Defaults upon Senior Securities	27
Item 4.	Submission of Matters to a Vote of Security Holders	27
Item 5.	Other Information	28
Item 6.	Exhibits	28
Signatures		29

PART I

ITEM 1. FINANCIAL STATEMENTS

Solar EnerTech Corp.

Condensed Consolidated Balance Sheets

	June 30, 2008			September 30, 2007
	(Unaudited)			(Audited)
ASSETS
Current assets:
Cash and cash equivalents	$	2,681,000		$	3,908,000
Accounts receivable		2,568,000			913,000
Advance payments and other		4,955,000			6,500,000
Inventories, net		9,312,000			5,708,000
VAT taxes receivable		2,601,000			-
Other receivable		1,438,000			590,000
Total current assets		23,555,000			17,619,000
Fixed assets, net of accumulated depreciation		8,300,000			3,215,000
Deferred financing costs, net of accumulated amortization		1,860,000			2,540,000
Deposits		3,105,000			1,741,000
Total assets	$	36,820,000		$	25,115,000

LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)
Current liabilities:
Accounts payable	$	589,000		$	2,891,000
Customer advance payment		1,184,000			1,603,000
Accrued interest expense		-			615,000
Accrued expenses		485,000			507,000
Accounts payable and accrued liabilities, related parties		3,969,000			3,969,000
Demand note payable to a related party		-			450,000
Demand notes payable		-			700,000
Derivative liabilities		2,500,000			16,800,000
Warrant liabilities		6,360,000			17,390,000
Total current liabilities		15,087,000			44,925,000
Convertible notes, net of discount		55,000			7,000
Total liabilities		15,142,000			44,932,000

Commitments and contingencies (Note 11)

STOCKHOLDER'S EQUITY (DEFICIT):
Common stock - 200,000,000 shares authorized at $0.001 par value 111,616,855 and 78,827,012 shares issued and outstanding at June 30, 2008 and September 30, 2007, respectively		112,000			79,000
Additional paid in capital		70,519,000			39,192,000
Other comprehensive income		2,361,000			592,000
Accumulated deficit		(51,314,000	)		(59,680,000	)
Total stockholders' equity (deficit)		21,678,000			(19,817,000	)
Total liabilities and stockholders' equity (deficit)	$	36,820,000		$	25,115,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

Solar EnerTech Corp.

Condensed Consolidated Statements of Operations

(Unaudited)

	Three Months Ended June 30,						Nine Months Ended June 30,
	2008			2007			2008			2007

Net sales	$	10,272,000		$	1,517,000		$	18,582,000		$	1,520,000
Cost of sales		(10,235,000	)		(1,507,000	)		(19,680,000	)		(1,513,000	)
Gross profit (loss)		37,000			10,000			(1,098,000	)		7,000

Operating expenses:
Selling, general & administrative		1,606,000			2,798,000			8,185,000			7,733,000
Research & development		198,000			7,000			483,000			113,000
Loss on debt extinguishment		1,529,000			-			3,996,000			-
Total operating expenses		3,333,000			2,805,000			12,664,000			7,846,000

Operating loss		(3,296,000	)		(2,795,000	)		(13,762,000	)		(7,839,000	)

Other income (expense):
Interest income		24,000			27,000			80,000			40,000
Interest expense		(238,000	)		(280,000	)		(814,000	)		(334,000	)
Loss on issuance of convertible notes		-			-			-			(15,209,000	)
Gain (loss) on change in fair market value of compound embedded derivative		(22,000	)		7,100,000			12,267,000			(5,500,000	)
Gain (loss) on change in fair market value of warrant liability		107,000			4,532,000			11,030,000			(5,427,000	)
Other expense		(107,000	)		(267,000	)		(435,000	)		(267,000	)
Net income (loss)	$	(3,532,000	)	$	8,317,000		$	8,366,000		$	(34,536,000	)

Net income (loss) per share - basic	$	(0.03	)	$	0.11		$	0.09		$	(0.44	)
Net income (loss) per share - diluted	$	(0.03	)	$	(0.03	)	$	(0.10	)	$	(0.44	)

Weighted average shares outstanding - basic		104,528,145			78,807,012			97,518,130			78,257,561
Weighted average shares outstanding - diluted		104,528,145			119,343,005			120,531,481			78,257,561

The accompanying notes are an integral part of these condensed consolidated financial statements.

Solar EnerTech Corp.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Nine Months Ended June 30,
	2008			2007
Cash flows from operating activities:
Net income (loss)	$	8,366,000		$	(34,536,000	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation of fixed assets		877,000			10,000
Stock-based compensation		4,777,000			6,349,000
Loss on issuance of convertible notes		-			15,209,000
Loss on debt extinguishment		3,996,000			-
Inventory reserve		438,000			-
Amortization of note discount and deferred financing cost		61,000			2,000
Loss (gain) on change in fair market value of compound embedded derivative		(12,267,000	)		5,500,000
Loss (gain) on change in fair market value of warrant liability		(11,030,000	)		5,427,000
Changes in operating assets and liabilities:
Accounts receivable		(1,339,000	)		(85,000	)
Advance payments and other		2,069,000			(2,774,000	)
Inventories, net		(3,485,000	)		(4,011,000	)
VAT taxes receivable		(2,601,000	)		-
Other receivable		(848,000	)		-
Accounts payable and accrued liabilities		(2,735,000	)		1,480,000
Customer advance payment		(419,000	)		794,000
Accounts payable and accrued liabilities, related parties		-			(35,000	)
Net cash used in operating activities		(14,140,000	)		(6,670,000	)

Cash flows from investing activities:
Acquisition of fixed assets		(5,482,000	)		(2,671,000	)
Deposits on equipment		(1,364,000	)		388,000
Net cash used in investing actives		(6,846,000	)		(2,283,000	)

Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering cost		19,887,000			1,089,000
Proceeds from note payable		-			100,000
Proceeds from issuance of convertible notes, net of offering cost		-			15,950,000
Net cash provided by financing activities		19,887,000			17,139,000

Effect of exchange rate on cash and cash equivalents		(128,000	)		84,000
Net increase (decrease) in cash and cash equivalents		(1,227,000	)		8,270,000
Cash and cash equivalents, beginning of period		3,908,000			2,799,000
Cash and cash equivalents, end of period	$	2,681,000		$	11,069,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

SOLAR ENERTECH CORP.

Notes to Condensed Consolidated Financial Statements

June 30, 2008 (Unaudited)

NOTE 1 — ORGANIZATION AND NATURE OF OPERATIONS

Solar EnerTech Corp. (formerly Safer Residence Corporation) was incorporated in Nevada, United States of America, on July 7, 2004. To facilitate a change in focus from providing customers with home security assistance services to the solar energy industry on March 27, 2006, Safer Residence Corp. merged with and into Solar EnerTech Corp., and on April 7, 2006, changed its name to Solar EnerTech Corp. (the “Company”).

On July 18, 2006, the Company executed an agency agreement with Solar EnerTech (Shanghai) Co., Ltd. (formerly known as Infotech (Shanghai) Solar Technologies Ltd.), effective April 10, 2006, to engage in business in China on its behalf. Infotech Shanghai is controlled through a Hong Kong company which is controlled by the Company’s President and CEO. See additional disclosures related to the agency agreement in Note 2 described below.

The Company was in the development stage through March 31, 2007. The quarter ended June 30, 2007 was the first quarter during which the Company was considered an operating company and no longer in the development stage.

On August 13, 2008 the Company reincorporated to the State of Delaware. See Note 13 of Notes to Condensed Consolidated Financial Statements for additional information.

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of consolidation and basis of accounting

These consolidated financial statements have been prepared in U.S. dollars and in accordance with accounting principles generally accepted in the United States of America, and include the accounts of Solar EnerTech and its wholly-controlled variable interest entities, Infotech (Hong Kong) Solar Technologies Ltd (“Infotech HK”) and Solar EnerTech (Shanghai) Co., Ltd. (formerly known as Infotech (Shanghai) Solar Technologies Ltd.) (“Infotech Shanghai”). Collectively, the variable interest entities are referred to in these financial statements as “Infotech”. Infotech HK is the holding company for Infotech Shanghai. Infotech HK does not have any investments or operations separate from Infotech Shanghai. All material intercompany accounts and transactions have been eliminated. The minority interests in Infotech were not significant at June 30, 2008 and as a result, no minority interest balance is reflected in these financial statements.

Variable interest entities

A variable interest entity (“VIE”) is an entity with an ownership, contractual or other financial interest held by a primary beneficiary that is determined by control attributes other than a majority voting interest. The Company’s contractual, financial and operating relationships with Infotech make the Company the primary beneficiary of Infotech’s losses, which are expected to extend into fiscal 2008 or longer, and any residual returns, if any, thereafter. Upon consolidation, the primary beneficiary records all of the VIE’s assets, liabilities and non-controlling interests as if it were consolidated based on a majority voting interest.

Under the Agency Agreement dated April 10, 2006, the Company engaged Infotech to undertake all activities necessary to build a solar technology business in China, including the acquisition of manufacturing facilities and equipment, employees and inventory. Because the Company and Infotech share the same managers and staff and the Company provides Infotech’s sole source of financial support, the companies effectively operate as parent and subsidiary. Infotech is not compensated for its services as agent; however, the Company is required to reimburse Infotech for the normal and usual expenses of managing the Company’s business activities as contemplated by the agreement. The Company does not have any responsibility to absorb costs incurred by Infotech beyond those incurred in its capacity as an agent for the Company, nor does the Company has any rights to future returns of Infotech that are not associated with them acting in their capacity as our agent. However, substantially all of Infotech’s operations consist of them acting as our agent.

Under the terms of the Agency Agreement, the Agency Agreement continues through its initial term ended April 10, 2008 term and remains effective on a month-to-month basis unless otherwise terminated. The Company may terminate the agreement at any time. While the Agency Agreement did not specifically provide the right for Infotech Shanghai to terminate the agreement after expiration of the initial term on April 10, 2008, Infotech Shanghai may presumably terminate the Agency Agreement at any time by electing not to continue. Upon termination of the agreement, (i) Infotech Shanghai is obligated to return any funds advanced by the Company for future expenses and deliver to the Company a final accounting of expenses incurred on behalf of the Company along with associated books and records and (ii) the Company is obligated to pay Infotech Shanghai any outstanding amounts owed to Infotech Shanghai. Upon termination of the Agency Agreement, shareholders of the Company would not have rights to the net assets of Infotech Shanghai which exist independent of the Agency Agreement. However, any property, plant and equipment purchased or constructed on behalf of the Company under the Agency Agreement which were funded by the Company are legally owned by the Company and not by Infotech Shanghai and therefore while the Agency Agreement does not specifically provide for the transfer of any of the net assets of Infotech Shanghai, under general principals of agency law, Infotech Shanghai would be required to transfer such assets to the Company upon request.

While Infotech is not a subsidiary of the Company, under Chinese law, funds held by Infotech for the operation of the Company’s business can be transferred from Infotech pursuant to an agreement such as the existing Agency Agreement. We are not aware of any significant currency or other restrictions on Infotech’s ability to perform under the Agency Agreement.

All of the Company’s business activities conducted in China are carried out by Infotech. As of June 30, 2008 and September 30, 2007, total assets held by Infotech as agent for the Company amounted to $33.0 million and $21.6 million, respectively. Total advances and reimbursements made to date from the Company to Infotech as of June 30, 2008 and September 30, 2007 were $34.4 million and $26.2 million, respectively, which effectively represent intercompany receivables to the Company from Infotech Shanghai which are eliminated during consolidation. Infotech’s operating expenses on behalf of Solar for the nine months ended June 30, 2008 and 2007 totaled $2.5 million and $0.7 million, respectively. Infotech’s only debt consisted of advances received from the Company.

Inventories

Inventories are stated at the lower of cost or market. Cost is determined by the weighted-average method. Raw material cost is based on purchase costs while work-in-progress and finished goods comprise of direct materials, direct labor and an allocation of manufacturing overhead costs. Inventory in-transit is included in finished goods and consists of products shipped but not recognized as revenue because they did not meet the revenue recognition criteria. Provisions are made for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of net realizable value.

Income taxes

The Company files federal and state income tax returns in the United States for its United States operations, and files separate foreign tax returns for its foreign subsidiary in the jurisdictions in which this entity operates. The Company accounts for income taxes under the provisions of SFAS No. 109, Accounting for Income Taxes (“SFAS 109”).

Under the provisions of SFAS 109, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between their financial statement carrying amounts and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

Valuation allowance

Significant judgment is required in determining any valuation allowance recorded against deferred tax assets. In assessing the need for a valuation allowance, we consider all available evidence including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies. In the event that we change our determination as to the amount of deferred tax assets that can be realized, we will adjust our valuation allowance with a corresponding impact to the provision for income taxes in the period in which such determination is made.

Unrecognized Tax Benefits

Effective on October 1, 2007, the Company adopted the provisions of Interpretation No. 48, “Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109” (“FIN 48”). Under FIN 48, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority based solely on the technical merits of the associated tax position. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. The Company also elected the accounting policy that requires interest recognized in accordance with Paragraph 15 of FIN 48 and penalties recognized in accordance with Paragraph 16 of FIN 48 be classified as part of its income taxes. The Company classifies the unrecognized tax benefits that are expected to result in payment or receipt of cash within one year as current liabilities, otherwise, the unrecognized tax benefits will be classified as non-current liabilities. Additionally, FIN 48 provides guidance on de-recognition, accounting in interim periods, disclosure and transition. See Note 6 of Notes to Condensed Consolidated Financial Statements for additional information.

Derivative financial instruments

Statement of Financial Accounting Standard No. 133 (“SFAS 133”), “Accounting for Derivative Instruments and Hedging Activities,” as amended, requires all derivatives to be recorded on the balance sheet at fair value. These derivatives, including embedded derivatives in our structured borrowings, are separately valued and accounted for on the balance sheet. Fair values for exchange-traded securities and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market based pricing models incorporating readily observable market data and requiring judgment and estimates.

In September 2000, the Emerging Issues Task Force issued EITF 00-19, “Accounting for Derivative Financial Instruments Indexed to and Potentially Settled in, a Company’s Own Stock,” (“EITF 00-19”) which requires freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument, an asset or a liability. Under the provisions of EITF 00-19, a contract designated as an asset or a liability must be carried at fair value on a company’s balance sheet, with any changes in fair value recorded in the company’s results of operations.

The Company’s management used market-based pricing models to determine the fair values of the Company’s derivatives. The model uses market-sourced inputs such as interest rates, exchange rates and option volatilities. Selection of these inputs involves management’s judgment and may impact net income.

The method used to estimate the value of the compound embedded derivatives (“CED”) as of each valuation date was a Monte Carlo simulation. Under this method the various features, restrictions, obligations and options related to each component of the CED were analyzed and spreadsheet models of the net expected proceeds resulting from exercise of the CED (or non-exercise) were created. Each model is expressed in terms of the expected timing of the event and the expected stock price as of that expected timing.

Because the potential timing and stock price may vary over a range of possible values, a Monte Carlo simulation was built based on the possible stock price paths (i.e., daily expected stock price over a forecast period). Under this approach an individual potential stock price path is simulated based on the initial stock price at the measurement date, the expected volatility and risk free rate over the forecast period. Each path is compared against the logic described above for potential exercise events (or non-exercise which result in $0 value) and the present value recorded. This is repeated over a significant number of trials, or individual stock price paths, in order to generate an expected or mean value for the present value of the CED.

The Company’s management used the binomial valuation model to value warrants issued in conjunction with convertible notes entered into in March 2007. The model uses inputs such as implied term, suboptimal exercise factor, volatility, dividend yield and risk-free interest rate. Selection of these inputs involves management’s judgment and may impact estimated value.

Stock-Based Compensation

On January 1, 2006, the Company began recording compensation expense associated with stock options and other forms of employee equity compensation in accordance with Statement of Financial Accounting Standards No. 123R, Share-Based Payment, as interpreted by SEC Staff Accounting Bulletin No. 107.

The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing formula and a single option award approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. The following assumptions are used in the Black-Scholes-Merton option pricing model:

Expected Term —The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding;

Expected Volatility— The Company’s expected volatilities are based on historical volatility of the Company’s stock, adjusted where determined by management for unusual and non-representative stock price activity not expected to recur. Due to the limited trading history, we also considered volatility data of guidance companies;

Expected Dividend —The Black-Scholes-Merton valuation model calls for a single expected dividend yield as an input. The Company currently pays no dividends and does not expect to pay dividends in the foreseeable future;

Risk-Free Interest Rate— The Company bases the risk-free interest rate on the implied yield currently available on United States Treasury zero-coupon issues with an equivalent remaining term; and

Estimated Forfeitures— When estimating forfeitures, the Company uses the average historical option forfeitures over a period of four years.

In conjunction with stock option awards granted to the President/CEO and a director in March 2006, the management estimated the fair value of the equity of the Company using a simple weighted average (50/50) of the Income Approach, Discounted Cash Flow Method (“Income Approach”), and Market Approach, Guideline Public Company Method (“Market Approach”). There were no discounts taken for this determination of the equity value of the Company.

For the Income Approach, management utilized a five year forecast of income and expenses, including capital expenditures, to determine debt-free cash flow. Management used a multiple of 2.9 times 2010 forecasted revenue to determine a terminal value for the Company. The multiple of 2.9 was based upon the median 2008 business enterprise value to revenue multiple of three comparable public companies in the same industry as the Company, and of similar size. The discrete cash flows and the terminal value were present-valued using a discount rate of fifty percent. The discount rate was based upon guideline discount rates for early stage companies from the AICPA Practice Aid Series, Valuation of Privately-Held-Company Equity Securities Issued as Compensation . The sum of the present values of the discrete cash flows plus the terminal value determined the business enterprise value of the Company. “Net Debt” was subtracted from the business enterprise value to determine the value of equity of the Company.

For the Market Approach, management used the same three guideline public companies that were used for the terminal value multiple to determine 1) a revenue multiple for the twelve months trailing the Valuation Date of March 1, 2006; 2) a revenue multiple for 2007; and 3) a revenue multiple for 2008 (the same multiple used to determine the terminal value of the Company). As the Company had no revenue for the trailing twelve months prior to the Valuation Date, management relied upon the revenue multiples for 2007 and 2008. Management applied the multiples to the revenue forecast of the Company for the years 2007 and 2008, and determined an equity value for the Company as an equally weighted average sum of the two multiples.

Revenue Recognition

The Company recognizes revenues from product sales in accordance with Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition, which states that revenue is realized or realizable and earned when all of the following criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and collectability is reasonably assured. Where a revenue transaction does not meet any of these criteria it is deferred and recognized once all such criteria have been met. In instances where final acceptance of the product, system, or solution is specified by the customer, revenue is deferred until all acceptance criteria have been met.

On a transaction by transaction basis, we determine if the revenue should be recorded on a gross or net basis based on criteria discussed in EITF99-19, Reporting Revenue Gross as a Principal versus Net as an Agent, (“ EITF99-19 ”) . We consider the following factors when we determine the gross versus net presentation: if the Company (i) acts as principal in the transaction; (ii) takes title to the products; (iii) has risks and rewards of ownership, such as the risk of loss for collection, delivery or return; and (iv) acts as an agent or broker (including performing services, in substance, as an agent or broker) with compensation on a commission or fee basis.

For the nine months ended June 30, 2008, approximately 12% of the Company’s revenue came from reselling of polysilicon or wafer raw materials. There was no such revenue for the quarter ended June 30, 2008. All transactions related to reselling of polysilicon or wafer raw materials incurred in fiscal year 2008 were recorded on a gross basis. For the three months ended June 30, 2008, approximately 13% of the Company’s revenue came from contract manufacturing of solar modules. We produced modules based on requirements specified by the customer. Our revenue related to contract manufacturing was recorded on a net basis based on criteria discussed in EITF 99-19.

Segment Information

The Company identifies its operating segments based on its business activities and geographical locations. The Company operates within a single operating segment - the manufacture of solar energy cells and modules. The Company operates in the United States and in China. All of the Company’s sales occurred in China and substantially all of the Company’s fixed assets are located in China.

Reclassifications

Certain amounts in the prior year financial statements have been reclassified to conform to the current year presentation. These reclassifications have no effect on previously reported results of operations. The Company has also reclassified current year to date amounts, specifically relating to stock-based compensation expense.

Recent Accounting Pronouncements

In September 2006, the FASB issued SFAS No. 157 (“SFAS 157”), “Fair Value Measurements.” SFAS 157 defines fair value to measure assets and liabilities, establishes a framework for measuring fair value, and requires additional disclosures about the use of fair value. SFAS 157 is applicable whenever another accounting pronouncement requires or permits assets and liabilities to be measured at fair value. SFAS 157 does not expand or require any new fair value measures. SFAS 157 is effective for fiscal years beginning after November 15, 2007. The Company is currently evaluating the impact that the adoption of FAS 157 will have on its financial position or results of operations.

In February 2007, the FASB issued SFAS No. 159 (“SFAS 159”), “The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of FASB Statement No. 115.” SFAS 159 expands the use of fair value accounting but does not affect existing standards which require assets or liabilities to be carried at fair value. The objective of SFAS 159 is to improve financial reporting by providing companies with the opportunity to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. Under SFAS 159, a company may elect to use fair value to measure eligible items at specified election dates and report unrealized gains and losses on items for which the fair value option has been elected in earnings at each subsequent reporting date. Eligible items include, but are not limited to, accounts and loans receivable, available-for-sale and held-to-maturity securities, equity method investments, accounts payable, guarantees, issued debt and firm commitments. If elected, SFAS 159 is effective for fiscal years beginning after November 15, 2007. The Company is currently assessing whether fair value accounting is appropriate for any of its eligible items and is in process of estimating the impact, if any, on its results of operations or financial position.

In December 2007, the FASB issued SFAS No. 160 (“SFAS 160”), “Non-controlling Interests in Consolidated Financial Statements, an amendment of ARB No. 51.” The standard changes the accounting for non-controlling (minority) interests in consolidated financial statements, including the requirements to classify non-controlling interests as a component of consolidated stockholders’ equity, and the elimination of “minority interest” accounting in results of operations with earnings attributable to non-controlling interests reported as part of consolidated earnings. Additionally, SFAS 160 revises the accounting for both increases and decreases in a parent’s controlling ownership interest. SFAS 160 is effective for the first annual reporting period beginning on or after December 15, 2008. Thus, SFAS 160 will be effective for the Company on October 1, 2009, with early adoption prohibited. The Company is evaluating the potential impact of the implementation of SFAS 160 on its financial position and results of operations.

In December 2007, the FASB issued SFAS No. 141 (revised) (“SFAS 141(R)”), “Business Combinations.” The standard changes the accounting for business combinations, including the measurement of acquirer shares issued in consideration for a business combination, the recognition of contingent consideration, the accounting for preacquisition gain and loss contingencies, the recognition of capitalized in-process research and development, the accounting for acquisition-related restructuring cost accruals, the treatment of acquisition related transaction costs, and the recognition of changes in the acquirer’s income tax valuation allowance. SFAS 141(R) is effective for the first annual reporting period beginning on or after December 15, 2008. Thus, SFAS 141(R) will be effective for the Company on October 1, 2009, with early adoption prohibited. The Company is evaluating the potential impact of the implementation of Statement 141(R) on its financial position and results of operations.

In March 2008, the FASB issued SFAS No. 161 (“SFAS 161”), “Disclosures about Derivative Instruments and Hedging Activities.” SFAS 161 requires additional disclosures related to the use of derivative instruments, the accounting for derivatives and how derivatives impact financial statements. SFAS 161 is effective for fiscal years and interim periods beginning after November 15, 2008. Thus, the Company is required to adopt this standard on January 1, 2009. The Company is currently evaluating the impact of adopting SFAS 161 on its financial position and results of operations.

In May 2008, the FASB issued SFAS No. 162 (“SFAS 162”), “The Hierarchy of Generally Accepted Accounting Principles”. SFAS 162 identifies the sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles (GAAP) in the United States (the GAAP hierarchy). This Statement is effective for financial statements issued 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. The Company is currently evaluating the impact of adopting SFAS 162 on its financial position and results of operations.

NOTE 3 — INVENTORIES

At June 30, 2008 and September 30, 2007, inventories consist of:

	June 30, 2008		September 30, 2007
Raw materials	$	4,636,000	$	2,724,000
Work in process		204,000		839,000
Finished goods		4,472,000		2,145,000
Total inventories	$	9,312,000	$	5,708,000

At June 30, 2008, the Company had $2.9 million of raw materials loaned to a customer in conjunction with the contract manufacturing arrangement.

NOTE 4 — ADVANCE PAYMENTS AND OTHER

At June 30, 2008 and September 30, 2007, advance payments and other consist of:

	June 30, 2008		September 30, 2007
Prepayment for raw materials	$	4,796,000	$	6,500,000
Others		159,000		-
Total advance payments and other	$	4,955,000	$	6,500,000

NOTE 5— FIXED ASSETS

At June 30, 2008 and September 30, 2007, fixed assets consist of:

	June 30, 2008			September 30, 2007
Production equipment	$	5,103,000		$	1,065,000
Leasehold improvement		2,235,000			1,615,000
Automobiles		539,000			333,000
Office equipment		352,000			88,000
Machinery		201,000			455,000
Furniture		38,000			38,000
Construction in progress		1,173,000			-
Total Fixed Assets		9,641,000			3,594,000
Less: Accumulated depreciation		(1,341,000	)		(379,000	)
Net Fixed Assets	$	8,300,000		$	3,215,000

NOTE 6 — INCOME TAX

The Company has no taxable income and no provision for federal and state income taxes is required for the three and nine months ended June 30, 2008 and June 30, 2007, respectively, except for certain minimum state taxes.

The Company accounts for income taxes using the liability method in accordance with Financial Accounting Standards Board Statement No. 109 (“SFAS 109”), “Accounting for Income Taxes”. SFAS 109 requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements, but have not been reflected in the Company’s taxable income. A valuation allowance is established to reduce deferred tax assets to their estimated realizable value. Therefore, the Company provides a valuation allowance to the extent that the Company does not believe it is more likely than not that the Company will generate sufficient taxable income in future periods to realize the benefit of the Company’s deferred tax assets. As of June 30, 2008 and June 30, 2007, the deferred tax asset was subject to a 100% valuation allowance and therefore is not recorded on the Company’s balance sheet as an asset. Realization of the Company’s deferred tax assets is limited and the Company may not be able to fully utilize these deferred tax assets to reduce the Company’s tax rates.

As of June 30, 2008, due to the history of losses the Company has generated in the past, the Company believes that it is more-likely-than-not that the deferred tax assets cannot be realized before the respective utilization expiration dates. Therefore, we have a full valuation allowance on our deferred tax assets. Utilization of the net operating loss carry forwards and credits may be subject to a substantial annual limitation due to the ownership change limitations provided by the Internal Revenue Code of 1986, as amended and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. The Company also has net operating losses in its foreign jurisdiction and that loss can be carried over 5 years from the year the loss was incurred.

In July 2006, the FASB issued FIN 48, which clarifies the accounting for uncertainty in income taxes recognized in any entity’s financial statements in accordance with SFAS 109 and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under FIN 48, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, FIN 48 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006.

The Company has adopted the provisions of FIN 48 on October 1, 2007. The total amount of unrecognized tax benefits as of the date of adoption was not material. As a result of the implementation of FIN 48, the Company recognized no increase in the liability for unrecognized tax benefits and no retained earnings adjustment as of October 1, 2007. We have adopted the accounting policy such that interest recognized in accordance with Paragraph 15 of FIN 48 and penalty recognized in accordance with Paragraph 16 of FIN 48 are classified as part of our income tax expense.

The Company is subject to taxation in the United States and China. There are no ongoing examinations by taxing authorities at this time. The Company has open tax years from 2004 to present in various taxing jurisdictions. Tax returns filed for these tax years may be audited by the applicable tax authorities.

NOTE 7— CONVERTIBLE NOTES

On March 7, 2007, the Company entered into a securities purchase agreement to issue $17,300,000 of secured convertible notes (the “notes”) and detachable stock purchase warrants (the “warrants”). Accordingly, during the three months ended March 31, 2007, the Company sold units consisting of:

•

$5,000,000 in principal amount of Series A Convertible Notes and warrants to purchase 7,246,377 shares (exercise price of $1.21 per share) of its common stock;

•

$3,300,000 in principal amount of Series B Convertible Notes and warrants to purchase 5,789,474 shares (exercise price of $0.90 per share) of its common stock; and

•

$9,000,000 in principal amount of Series B Convertible Notes and warrants to purchase 15,789,474 shares (exercise price of $0.90 per share) of its common stock.

These notes bear interest at 6% per annum and are due in 2010. The principal amount of the Series A Convertible Notes may be converted at the initial rate of $0.69 per share for a total of 7,246,377 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest). The principal amount of the Series B Convertible Notes may be converted at the initial rate of $0.57 per share for a total of 21,578,948 shares of common stock (which amount does not include shares of common stock that may be issued for the payment of interest).

In connection with the issuance of the notes and warrants, the Company engaged an exclusive advisor and placement agent (the “advisor”) and issued warrants to the advisor to purchase an aggregate of 1,510,528 shares at an exercise price of $0.57 per share and 507,247 shares at an exercise price of $0.69 per share, of the Company’s common stock (the “advisor warrants”). In addition to the issuance of the warrants, the Company paid $1,038,000 in commissions, an advisory fee of $173,000, and other fees and expenses of $84,025.

The Company evaluated the notes for derivative accounting considerations under SFAS 133 and EITF 00-19 and determined that the notes contain two embedded derivative features, the conversion option and a redemption privilege accruing to the holder if certain conditions exist (the “compound embedded derivative”). The compound embedded derivative is measured at fair value both initially and in subsequent periods. Changes in fair value of the compound embedded derivative are recorded in the account “gain (loss) on fair market value of compound embedded derivative” in the accompanying consolidated statements of operations.

The warrants (including the advisor warrants) are classified as a liability, as required by SFAS No. 150, due to the terms of the warrant agreement which contains a cash redemption provision in the event of a fundamental transaction. The warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account “gain (loss) on fair market value of warrant liability” in the accompanying consolidated statements of operations.

The following table summarizes the valuation of the notes, the warrants (including the advisor warrants), and the compound embedded derivative:

	Amount
Proceeds of convertible notes	$	17,300,000
Allocation of proceeds:
Fair value of warrant liability (excluding advisor warrants)		(15,909,000	)
Fair value of compound embedded derivative liability		(16,600,000	)
Loss on issuance of convertible notes		15,209,000
Carrying amount of notes at grant date	$	-

Amortization of note discount	$	7,000
Carrying amount of notes at September 30, 2007		7,000
Amortization of note discount		48,000
Carrying amount of notes at June 30, 2008	$	55,000

Fair value of warrant liability (including advisor warrants) at issuance	$	17,100,000
Loss on fair market value of warrant liability		290,000
Fair value of warrant liability at September 30, 2007		17,390,000
Gain on fair market value of warrant liability		(11,030,000	)
Fair value of warrant liability at June 30, 2008	$	6,360,000

Fair value of compound embedded derivative at grant date	$	16,600,000
Loss on fair market value of embedded derivtive liability		200,000
Fair value of compound embedded derivative at September 30, 2007		16,800,000
Gain on fair market value of embedded derivative liability		(12,267,000	)
Conversion of Series A and B Notes		(2,033,000	)
Fair value of compound embedded derivative at June 30, 2008	$	2,500,000

The value of the warrants (including the advisor warrants) was estimated using a binomial valuation model with the following assumptions:

	June 30, 2008			September 30, 2007
Implied term (years)		3.68			4.43
Suboptimal exercise factor		2.5			2.5
Volatility		82	%		72	%
Dividend yield		0	%		0	%
Risk free interest rate		3.06	%		4.23	%

In conjunction with March 2007 financing, we recorded total deferred financing cost of $2.5 million, of which $1.3 million represented cash payment and $1.2 million represented the fair market value of the advisor warrants. The deferred financing cost is amortized over the three year life of the notes using a method that approximates the effective interest rate method. The advisor warrants were recorded as a liability and adjusted to fair value in each subsequent period. As of June 30, 2008, total unamortized deferred financing cost was $1.9 million.

The method used to estimate the value of the CED as of each valuation date was a Monte Carlo simulation. Under this method the various features, restrictions, obligations and option related to each component of the CED were analyzed and spreadsheet models of the net expected proceeds resulting from exercise of the CED (or non-exercise) were created. Each model is expressed in terms of the expected timing of the event and the expected stock price as of that expected timing.

Because the potential timing and stock price may vary over a range of possible values, a Monte Carlo simulation was built based on the possible stock price paths (i.e., daily expected stock price over a forecast period). Under this approach an individual potential stock price path is simulated based on the initial stock price at the measurement date, the expected volatility and risk free rate over the forecast period. Each path is compared against the logic describe above for potential exercise events and the present value (or non-exercise which result in $0 value) recorded. This is repeated over a significant number of trials, or individual stock price paths, in order to generate an expected or mean value for the present value of the CED.

The significant assumptions used in estimating stock price paths as of each valuation date are:

	June 30, 2008			September 30, 2007
Starting stock price (closing price on date preceding valuation date)	$	0.59		$	1.28
Annual volatility of stock		82.30	%		72.10	%
Risk free rate		2.63	%		3.97	%

Additional assumptions were made regarding the probability of occurrence of each exercise scenario, based on stock price ranges (based on the assumption that scenario probability is constant over narrow ranges of stock price). The key scenarios included public offering, bankruptcy and other defaults.

During the quarter ended June 30, 2008, $1.5 million of Series A and B convertible notes were converted into our common shares. We recorded a loss on debt extinguishment of $1.5 million as a result of the conversion based on the quoted market closing price of our common shares on the conversion dates. For the nine months ended June 30, 2008, $4.6 million of Series A and B convertible notes were converted into our common shares. We recorded a loss on debt extinguishment of $4.4 million as a result of the conversion based on the quoted market closing price of our common shares on the conversion dates.

The loss on debt extinguishment is computed at the conversion dates as follow:

	Three Months Ended			Nine Months Ended
	June 30, 2008			June 30, 2008
Fair value of the common shares	$	1,735,000		$	5,743,000
Unamortized deferred financing costs associated with the converted notes		224,000			673,000
Fair value of the CED liability associated with the converted notes		(422,000	)		(2,033,000	)
Accreted amount of the notes discount		(8,000	)		(13,000	)
Loss on debt extinguishment	$	1,529,000		$	4,370,000

For the nine months ended June 30, 2008, we recorded $4.4 million of loss on debt extinguishment from Series A and B convertible notes. This loss was offset by a gain on debt extinguishment from settlement agreement with Coach Capital LLC in the amount of $0.4 million (see Note 8 below). The net amount of $4.0 million loss on debt extinguishment is included in the Consolidated Statements of Operations.

NOTE 8 — EQUITY TRANSACTIONS

Common stock issued for repayment of loans

During the quarter ended December 31, 2007, the Company was informed by Thimble Capital that it had assigned the note payable of $100,000 due from us to Coach Capital LLC. The Company was also informed by Infotech Essentials Ltd. that it had assigned the note payable of $450,000 due from us to Coach Capital LLC.

On December 20, 2007, we entered into a settlement agreement with Coach Capital LLC to settle all outstanding notes payable in the amount of $1.2 million and related interest in exchange for the issuance of the Company’s common stock. The share price stated in the settlement agreement was $1.20 per share. The Company’s shares of common stock were valued at $0.84 per share, the closing price, on December 20, 2007. As a result, the Company recorded a gain on extinguishment of debt of $0.4 million.

Warrants

During November 2006, in connection with the sale of the Company’s common stock, the board of directors approved the issuance of a warrant to purchase an additional 2,500,000 shares of the Company’s common stock. The warrant is exercisable at $1 per share and expired as of November 20, 2007.

The fair value of the warrants issued in May through November 2006 in connection with the purchase of common stock has been allocated on a relative fair value basis between the value of the common stock and the warrants issued using the Black-Scholes -Merton option pricing model with the following assumptions: a risk-free interest rate of 4.50%, no dividend yield, a volatility factor of 82.57% and a contract life of one year.

During March 2007, in conjunction with the issuance of $17,300,000 in convertible debt, the board of directors approved the issuance of warrants (as described in Note 7 above) to purchase shares of the Company’s common stock. The 7,246,377 series A warrants and the 21,578,948 series B warrants are exercisable at $1.21 and $0.90, respectively and expire in March 2012. In addition, in March 2007, as additional compensation for services as placement agent for the convertible debt offering, the Company issued the advisor warrants, which entitle the placement agent to purchase 507,247 and 1,510,528 shares of the Company’s common stock at exercise prices of $0.69 and $0.57 per share, respectively. The advisor warrants expire in March 2012.

On January 11, 2008, the Company sold 24,318,181 shares of its common stock and 24,318,181 Series C warrants to purchase shares of Common Stock for an aggregate purchase price of $21.4 million in a private placement offering to accredited investors. The exercise price of the warrants is $1.00 per share. The warrants are exercisable for a period of 5 years from the date of issuance of the warrants.

For the services in connection with this closing, the placement agent and the selected dealer, Knight Capital Markets, LLC and Ardour Capital Investments, received an aggregate of a 6.0% cash commission, a 1.0% advisory fee and warrants to purchase 1,215,909 shares of common stock at $0.88 per share, exercisable for a period of 5 years from the date of issuance of the warrants. The net proceeds from issuing common stocks and Series C warrants in January 2008 after all the financing costs were $19.9 million and were recorded in additional paid in capital and common stock. Neither the shares of common stock nor the shares of common stock underlying the warrants sold in this offering were granted registration rights. Additionally, in connection with the offering all of our Series A and Series B warrant holders waived their full ratchet anti-dilution and price protection rights previously granted to them in connection with our March 2007 convertible note and warrant financing.

The warrants (including the advisor warrants) are classified as a liability in accordance with SFAS No. 150, as interpreted by FASB Staff Position 150-1 “Issuer’s Accounting for Freestanding Financial Instruments Composed of More Than One Option or Forward Contract Embodying Obligations under FASB Statement No. 150, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity”, due to the terms of the warrant agreements which contain cash redemption provisions in the event of a fundamental transaction, which provide that the Company would repurchase any unexercised portion of the warrants at the date of the occurrence of the fundamental transaction for the value as determined by the Black-Scholes Merton valuation model. As a result, the warrants are measured at fair value both initially and in subsequent periods. Changes in fair value of the warrants are recorded in the account “gain (loss) on fair market value of warrant liability” in the accompanying Consolidated Statements of Operations.

A summary of warrant activities through June 30, 2008 is as follows:

	Number of Shares			Exercise Price ($)		Recognized as
Granted in connection with common stock purchase		2,500,000			1.00		Additional paid in capital
Granted in connection with convertible notes — Series A		7,246,377			1.21		Discount to notes payable
Granted in connection with convertible notes — Series B		21,578,948			0.90		Discount to notes payable
Granted in connection with placement service		507,247			0.69		Deferred financing cost
Granted in connection with placement service		1,510,528			0.57		Deferred financing cost
Outstanding at September 30, 2007		33,343,100
Granted in connection with common stock purchase — Series C		24,318,181			1.00		Additional paid in capital
Granted in connection with placement service		1,215,909			0.88		Additional paid in capital
Expired		(2,500,000	)		1.00		Additional paid in capital
Outstanding at June 30, 2008		56,377,190

At June 30, 2008, the range of warrant prices for shares under warrants and the weighted-average remaining contractual life is as follows:

Warrants Outstanding and Exercisable
					Weighted-
			Weighted-		Average
Range of			Average		Remaining
Warrant	Number of		Exercise		Contractual
Exercise Price	Warrants		Price		Life
$0.57-$0.69		2,017,775	$	0.60		3.71
$0.88-$1.00		47,113,038	$	0.95		4.16
$1.21		7,246,377	$	1.21		3.69

Options

Non-Plan Options

Pursuant to an option agreement dated March 1, 2006 between Jean Blanchard, a former officer and director, and the President of the Company, the President has the right and option to purchase a total of 36,000,000 shares of the Company’s common stock at a price of $0.0001 per share, until February 10, 2010. The options granted under the agreement vest in three equal installments over a period of two years, with the first installment vesting immediately, and the remaining installments vesting at 12 and 24 months after the date of the agreement. During the year ended September 30, 2006, the President exercised 10,750,000 options to purchase 10,750,000 shares and transferred 5,750,000 shares to various employees of Infotech Shanghai. The Company recorded a stock compensation charge of $10.7 million in the fiscal year ended September 30, 2006 for the transfer of shares to the employees.

Pursuant to an option agreement dated March 1, 2006 between Jean Blanchard, a former officer and director of the Company, and Frankie Xie, a former director of the Company, Mr. Xie has the right and option to purchase a total of 1,500,000 shares of the Company’s common stock at a price of $0.0001 per share, until February 10, 2010. The options granted under the agreement vested immediately. Mr. Xie exercised the 1,500,000 shares of the Company’s common stock in April 2008.

The fair value of the options granted under these agreements was estimated at $26.4 million using the Black-Scholes stock price valuation model with the following assumptions:

•

Volatility of 82.57%;

•

Risk-free interest rate of 4.65%;

•

Expected lives - 4 years;

•

No dividend yield; and

•

Market value per share of stock on measurement date of $0.70.

Summary information regarding these options as of June 30, 2008 is as follows:

									Options Outstanding
											Weighted
	Number								Number		Average		Weighted
	of								Outstanding		Remaining		Average
	Options				Exercise				At June		Contractual		Exercise
	Granted		Expiration Date		Price		Exercised		30, 2008		Life (year)		Price
Granted to Leo Young, the President, March 1, 2006		36,000,000		February 10, 2010	$	0.0001		10,750,000		25,250,000		1.62	$	0.0001
Granted to Frank Fang Xie, a former director, March 1, 2006		1,500,000		February 10, 2010	$	0.0001		—		1,500,000		1.62	$	0.0001
Total		37,500,000						10,750,000		26,750,000		1.62

Mr. Xie’s option vested on the grant date in March 2006. The option to purchase 25.3 million shares of the Company’s common stock for Mr. Young has vested in March 2008.

2007 Equity Incentive Plan

In September 2007, the Company adopted the 2007 Stock Incentive Plan (the “Plan”) that allows the Company to grant non-statutory stock options to employees, consultants and directors. A total of 10,000,000 shares of the Company’s common stock are authorized for issuance under the Plan. The maximum number of shares that may be issued under the Plan will be increased for any options granted that expire, are terminated or repurchased by the Company for an amount not greater than the holder’s purchase price and may also be adjusted subject to action by the stockholders for changes in capital structure. Stock options may have exercise prices of not less than 100% of the fair value of a share of stock at the effective date of the grant of the option.

These options vest over various periods up to four years and expire no more than ten years from the date of grant. A summary of activity under this Plan is as follows:

	Shares Available For Grant			Number of Shares			Weighted Average Fair Value Per Share		Weighted Average Exercise Price Per Share
Balance at September 30, 2006		—			—			—		—
Shares reserved		10,000,000			—
Options granted		(7,300,000	)		7,300,000		$	0.66	$	1.20
Options exercised		—			—			—		—
Options cancelled		—			—			—		—
Balance at September 30, 2007		2,700,000			7,300,000		$	0.66	$	1.20
Options cancelled		298,958			(298,958	)	$	0.55	$	1.20
Options granted		(870,000	)		870,000		$	0.37	$	0.61
Balance at June 30, 2008		2,128,958			7,871,042		$	0.38	$	0.62

At June 30, 2008 and September 30, 2007, 7,871,042 and 7,300,000 options were outstanding, respectively and had a weighted-average remaining contractual life of 9.28 years and an exercise price of $0.62 and $1.20, respectively. Of these options, 2,694,590 and 1,453,338 shares were vested and exercisable on June 30, 2008 and September 30, 2007, respectively. The fair values of employee stock options granted were estimated using the Black-Scholes option-pricing model with the following weighted average assumptions:

	Three Months Ended			Nine Months Ended
	June 30, 2008			June 30, 2008
Volatility		99.2	%		99.2	%
Expected dividend		0.0	%		0.0	%
Risk-free interest rate		2.24	%		2.38	%
Expected term in years		2.2			2.6
Weighted-average fair value	$	0.36		$	0.37

On May 5, 2008, at the Company’s Annual Meeting of Stockholders, the Company’s stockholders approved an amendment and restatement of the Plan, which, among other things, will increase the maximum number of shares of Common Stock that may be issued under the Plan from 10,000,000 shares to 15,000,000 shares upon its effectiveness upon the Company’s anticipated reincorporation to the State of Delaware.

On May 9, 2008, the Compensation Committee of the Board of Directors of the Company authorized the repricing of all outstanding options issued to current employees, directors, officers and consultants prior to February 5, 2008 under the Company’s 2007 Equity Incentive Plan ("Plan") to $0.62, determined in accordance with the Plan as the closing price for shares of Common Stock on the Over-the-Counter Bulletin Board on the date of the repricing.

The Company repriced a total of 7,720,000 shares of Common Stock underlying outstanding options. The other terms of the options, including the vesting schedules, remained unchanged as a result of the repricing. Total additional compensation expense on non-vested options relating to the May 9, 2008 repricing is approximately $0.4 million which will be expensed ratably over the remaining vesting period. Additional compensation expense on vested options relating to the May 9, 2008 repricing is approximately $0.3 million which was fully expensed as of June 30, 2008. The repriced options had originally been issued with $0.94 to $1.65 per share option exercise prices, which prices reflected the then current market prices of our stock on the dates of original grant. As a result of the recent sharp reduction in our stock price, our Board of Directors believed that such options no longer would properly incentivize our employees, officers, directors and consultants who held such options to work in the best interests of our company and stockholders.

In accordance with the provisions of SFAS 123(R), the Company has recorded stock-based compensation expense of $0.6 million and $4.8 million for the three months and nine months ended June 30, 2008, respectively, which include the compensation effect for the options repriced. The stock-based compensation expense is based on the fair value of the options at the grant date.

NOTE 9 — OTHER COMPREHENSIVE INCOME

The components of comprehensive income (loss) were as follows:

	Three Months Ended June 30,					Nine Months Ended June 30,
	2008			2007		2008		2007
Net income (loss)	$	(3,532,000	)	$	8,317,000	$	8,366,000	$	(34,536,000	)
Other comprehensive income:
Change in foreign currency translation		484,000			74,000		1,769,000		84,000
Comprehensive income (loss)	$	(3,048,000	)	$	8,391,000	$	10,135,000	$	(34,452,000	)

Accumulated other comprehensive income at June 30, 2008 and September 30, 2007 is comprised of accumulated translation adjustments of $2.4 million and $0.6 million, respectively.

NOTE 10 — NET INCOME (LOSS) PER SHARE

The following table presents the computation of basic and diluted net income (loss) per share applicable to common stockholders:

	Three Months Ended						Nine Months Ended
	June 30, 2008			June 30, 2007			June 30, 2008			June 30, 2007

Calculation of net income (loss) per share - basic:

Net income (loss)	$	(3,532,000	)	$	8,317,000		$	8,366,000		$	(34,536,000	)
Weighted-average number of common shares outstanding		104,528,145			78,807,012			97,518,130			78,257,561
Net income (loss) per share - basic	$	(0.03	)	$	0.11		$	0.09		$	(0.44	)

Calculation of net loss per share - diluted:

Net income (loss)	$	(3,532,000	)	$	8,317,000		$	8,366,000		$	(34,536,000	)
Less: Gain on change in fair market value of compound embedded derivative		—			(7,100,000	)		(12,267,000	)		—
Interest expense on convertible notes		—			259,000			814,000			—
Less: Gain on change in fair market value of advisor warrants		—			—			(765,000	)		—
Less: Gain on change in fair market value of Series B warrants		—			(4,531,000	)		(7,786,000	)		—
Net loss assuming dilution	$	(3,532,000	)	$	(3,055,000	)	$	(11,638,000	)	$	(34,536,000	)

Weighted-average number of common shares outstanding		104,528,145			78,807,012			97,518,130			78,257,561
Effect of potentially dilutive securities:
Warrants issued to advisors		—			11,710,668			511,102			—
Convertible notes		—			28,825,325			21,397,371			—
Series B Warrants		—			—			1,104,878			—
Weighted-average number of common shares outstanding assuming dilution		104,528,145			119,343,005			120,531,481			78,257,561

Net loss per share - diluted	$	(0.03	)	$	(0.03	)	$	(0.10	)	$	(0.44	)

NOTE 11 — COMMITMENTS AND CONTINGENCIES

Capital investments

Pursuant to a joint research and development laboratory agreement with Shanghai University, dated December 15, 2006 and expiring on December 15, 2016, the Company is committed to fund the establishment of laboratories and completion of research and development activities. The Company committed to invest no less than RMB5 million each year for the first three years and no less than RMB30 million cumulatively for the first five years. The following table summarizes the commitments in U.S. dollar based upon a translation of the RMB amounts into U.S. dollars at an exchange rate of 6.8591.

Year	Amount
2008 (Remaining balance)*	$	966,000
2009		933,000
2010		933,000
2011		1,108,000
Total	$	3,940,000

The amount includes approximately $149,000 of 2007 commitment, which remained unpaid as of June 30, 2008. The Company intended to increase research and development spending as we grow our business. The payment to Shanghai University will be used to fund program expenses and equipment purchase. The delay in payment could lead to Shanghai University requesting the Company to pay the committed amount within a certain time frame. If the Company is still not able to correct the breach within the time frame, Shanghai University could seek compensation up to an additional 15% of the committed amount which would then total a 2007 commitment of approximately $656,000. As of the date of this report, we have not received any request from Shanghai University.

The agreement is for shared investment in research and development on fundamental and applied technology in the fields of semi-conductive photovoltaic theory, materials, cells and modules. The agreement calls for Shanghai University to provide equipment, personnel and facilities for joint laboratories. The Company will provide funding, personnel and facilities for conducting research and testing. Research and development achievements from this joint research and development agreement will be available to both parties. The Company is entitled to intellectual property rights including copyrights and patents obtained as a result of this research.

Expenditures under his agreement are accounted for as research and development expenditures under Statement of Financial Accounting Standard No. 2, “Accounting for Research and Development Costs” and expensed as incurred.

NOTE 12 — RELATED PARTY TRANSACTIONS

At June 30, 2008, accounts payable and accrued liabilities, related party, of $4 million primarily represent compensation expense related to the Company’s obligation to withhold tax upon exercise of stock options by our President and CEO of the transaction incurred in the fiscal year 2006. The amount represents the Company’s estimate of the tax withholding obligation.

NOTE 13 - SUBSEQUENT EVENTS

Reincorporation

On August 13, 2008, the Company entered into an Agreement and Plan of Merger with Solar EnerTech Corp., a Delaware corporation and wholly owned subsidiary of the Company (“Solar EnerTech Delaware”), whereby the Company merged with and into Solar EnerTech Delaware in order to effect a reincorporation changing the Company’s state of domicile from Nevada to Delaware (the “Reincorporation”). After the Reincorporation, the Company ceased to exist and Solar EnerTech Delaware was the surviving entity.

The Reincorporation was duly approved by both the Company’s Board of Directors and a majority of the Company’s stockholders at its annual meeting of stockholders held on May 5, 2008. On August 13, 2008, the Reincorporation was completed. The Reincorporation into Delaware did not result in any change to the Company’s business, management, employees, directors, capitalization, assets or liabilities.

ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

All references to “Solar EnerTech”, the “Company,” “we,” “our,” and “us” refer to Solar EnerTech Corp. and its subsidiaries.

The following discussion contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, readers can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue.” These statements relate to events that involve known and unknown risks, uncertainties and other factors, including those listed under the heading “Risks Related to Our Business,” “Risks Related to an Investment in Our Securities” and under the heading “Risks Related To an Investment in Our Securities” in our Form 10-KSB filed with the Securities and Exchange Commission (the “SEC”) on December 28, 2007 as well as other relevant risks detailed in our filings with the SEC which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The information set forth in this report on Form 10-Q should be read in light of such risks and in conjunction with the consolidated financial statements and the notes thereto included elsewhere in this Form 10-Q.

Overview

We were incorporated under the laws of the state of Nevada on July 7, 2004 and engaged in a variety of businesses, including home security assistance, until March 2006, when we began our current operations. We manufacture and sell photovoltaic (commonly known as “PV”) cells and modules. PV modules consist of solar cells that produce electricity from the sun’s rays. Our manufacturing operations are based in Shanghai, China, where we established a 63,000 square-foot manufacturing facility. We also plan to expand our marketing, purchasing and distribution office in Menlo Park, California. While we expect to sell most of our products in Europe, the United States and China, our goal is to become a worldwide supplier of PV cells.

We currently have one 25MW solar cell production line and 50MW solar module production facility. We intend to expand our solar cell production and add a second production line. We expect the second production line to be completed by the end of the 2008 calendar year.

During the quarter ended June 30, 2008, we recorded revenue of $10.3 million. A majority of the sales were to Sky Solar (Hong Kong) International Co., Ltd. (“Sky Solar”), a contract we previously disclosed in our Form 10-Q for the quarter ended March 31, 2008. We also shipped to other customers in Europe and Australia. Approximately 36% of modules shipped during the quarter used our own solar cells. The remaining cells were purchased from a third party. We are ramping up our solar cell production and expect to produce majority of the modules using our own cells in the fourth fiscal quarter 2008.

On January 11, 2008, we sold 24,318,181 shares of our common stock and 24,318,181 Series C warrants to purchase shares of common stock for an aggregate purchase price of $21.4 million in a private placement offering to accredited investors. The exercise price of the warrants is $1.00 per share. The warrants are exercisable for a period of 5 years from the date of issuance of the warrants. We used the net proceeds from the offering for working capital and general corporate purposes.

Our future operations are dependent upon the identification and successful completion of additional long-term or permanent equity financing, the support of creditors and shareholders, and, ultimately, the achievement of profitable operations. Other than as discussed in this report, we know of no trends, events or uncertainties that are reasonably likely to impact our future liquidity.

Critical Accounting Policies

We consider our accounting policies related to principles of consolidation, revenue recognition, inventory reserve, and stock based compensation, fair value of equity instruments and derivative financial instruments to be critical accounting policies. A number of significant estimates, assumptions, and judgments are inherent in determining our consolidation policy, when to recognize revenue, how to evaluate our equity instruments and derivative financial instruments, and the calculation of our inventory reserve and stock-based compensation expense. We base our estimates and judgments on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates. Management believes that there have been no significant changes during the nine months ended June 30, 2008 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis or Plan of Operations in our Annual Report on Form 10-KSB filed for the year ended September 30, 2007 with the Securities and Exchange Commission. For a description of those critical accounting policies, please refer to our 2007 Annual Report on Form 10-KSB.

Recent Accounting Pronouncements

In May 2008, the FASB issued SFAS No. 162 (“ SFAS 162”), “The Hierarchy of Generally Accepted Accounting Principles”. SFAS 162 identifies the sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles (GAAP) in the United States (the GAAP hierarchy). This Statement is effective for financial statements issued 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. The Company is currently evaluating the impact of adopting SFAS 162 on its financial position and results of operations.

Results of Operations for the three and nine months ended June 30, 2008 and 2007

The following discussion of the financial condition, results of operations, cash flows and changes in financial position of our Company should be read in conjunction with our audited consolidated financial statements and notes filed with the SEC on Form 10-KSB and its subsequent amendments.

Revenues, Cost of Sales and Gross Margin

	Three Months Ended June 30, 2008						Three Months Ended June 30, 2007						Year-Over-Year Change
	Amount			% of net sales			Amount			% of net sales			Amount			% of change
Net sales	$	10,272,000			100.	%	$	1,517,000			100.	%	$	8,755,000			577.1	%
Cost of sales		(10,235,000	)		(99.6	)%		(1,507,000	)		(99.3	)%		(8,728,000	)		579.2	%
Gross profit (loss)	$	37,000			0.4	%	$	10,000			0.7	%	$	27,000			270.	%

	Nine Months Ended June 30, 2008						Nine Months Ended June 30, 2007						Year-Over-Year Change
	Amount			% of net sales			Amount			% of net sales			Amount			% of change
Net sales	$	18,582,000			100.	%	$	1,520,000			100.	%	$	17,062,000			1,122.5	%
Cost of sales		(19,680,000	)		(105.9	)%		(1,513,000	)		(99.5	)%		(18,167,000	)		1,200.7	%
Gross profit (loss)	$	(1,098,000	)		(5.9	)%	$	7,000			0.5	%	$	(1,105,000	)		(15,785.7	)%

For the three months ended June 30, 2008, the Company reported total revenue of $10.3 million compared to $1.5 million of revenue in the same period of the prior year. The revenue of $10.3 million during the three months ended June 30, 2008 primarily represented solar module sales of $9.0 million and contract manufacturing revenue of $1.3 million. The majority of the modules purchased by Sky Solar under the contract, which was previously disclosed in our Form 10-Q for the quarter ended March 31, 2008 were delivered during the quarter ended June 30, 2008. Besides Sky Solar, our modules were shipped to customers in Australia, Holland, Germany, Switzerland and Belgium. For contract manufacturing arrangement, we produced modules based on requirements specified by the customer.

For the nine months ended June 30, 2008, the Company recorded $18.6 million in revenue which was comprised of $14.3 million in solar module sales, $1.3 million in contract manufacturing revenue, $0.7 million in solar cell sales, and $2.3 million in resale of raw materials compared to $1.5 million of revenue in the same period of the prior year. We generated revenue from resale of raw materials such as silicon wafer because we were over-stocked due to our still-limited production capability.

For the three months ended June 30, 2008 and 2007, we incurred a gross profit of $37,000 and $10,000, respectively. The positive gross margin in the third quarter 2008 was primarily attributable to sales of our solar module compared to the prior year period where gross margin benefited primarily from the resale of raw materials.

For the nine months ended June 30, 2008, we incurred a negative gross margin of $1.1 million mainly from high manufacturing costs due to increased raw material cost and production inefficiencies associated with our low production volume.

Selling, general & administrative

	Three Months Ended June 30, 2008					Three Months Ended June 30, 2007					Year-Over-Year Change
	Amount		% of net sales			Amount		% of net sales			Amount			% of change
Selling, general & administrative	$	1,606,000		15.6	%	$	2,798,000		184.4	%	$	(1,192,000	)		(42.6	)%

	Nine Months Ended June 30, 2008					Nine Months Ended June 30, 2007					Year-Over-Year Change
	Amount		% of net sales			Amount		% of net sales			Amount		% of change
Selling, general & administrative	$	8,185,000		44.	%	$	7,733,000		508.8	%	$	452,000		5.8	%

For the three months ended June 30, 2008, we incurred selling, general and administrative expense of $1.6 million, representing a decrease of $1.2 million or 43% from $2.8 million in the three months ended June 30, 2007. The selling, general and administrative expense included stock-based compensation expense related to employee options of $0.5 million and $2.1 million for the three months ended June 30, 2008 and 2007, respectively. Excluding stock-based compensation expense, our selling, general & administrative costs increased by approximately $0.4 million largely from increases in professional fees, the number of additional employees hired as we grow our business, and increased sales and marketing activities.

For the nine months ended June 30, 2008, we incurred selling, general and administrative expense of $8.2 million, representing an increase of $0.5 million or 5.8% from the $7.7 million incurred in the nine months ended June 30, 2007. The selling, general and administrative expense included stock-based compensation expense related to employee options of $4.7 million and $6.3 million for nine months ended June 30, 2008 and 2007, respectively. The overall increase in the selling, general and administrative expense excluding stock-based compensation was primarily related to increases in professional fees and the number of additional employees hired as we grow our business, and increased sales and marketing activities.

Research & development

	Three Months Ended June 30, 2008					Three Months Ended June 30, 2007					Year-Over-Year Change
	Amount		% of net sales			Amount		% of net sales			Amount		% of change
Research & development	$	198,000		1.9	%	$	7,000		0.5	%	$	191,000		2,728.6	%

	Nine Months Ended June 30, 2008					Nine Months Ended June 30, 2007					Year-Over-Year Change
	Amount		% of net sales			Amount		% of net sales			Amount		% of change
Research & development	$	483,000		2.6	%	$	113,000		7.4	%	$	370,000		327.4	%

Research and development expense represents expense incurred in-house as well as for the joint research and development program with Shanghai University. Research and development expense increased in the three and nine months ended June 30, 2008 and 2007 largely as a result of our commitment to fund our development contract with Shanghai University. In accordance with our joint research and development laboratory agreement with Shanghai University, dated December 15, 2006 and expiring on December 15, 2016, we are committed to funding an additional $1.0 million in fiscal year 2008 and $3.0 million in the next 3 years. The delay in payment could lead to Shanghai University requesting the Company to pay the committed amount within a certain time frame. If the Company is still not able to correct the breach within the time frame, Shanghai University could seek compensation up to an additional 15% of the committed amount which would then total a 2007 commitment of approximately $656,000. As of the date of this report, we have not received any compensation request from Shanghai University. We expect to increase our funding to research and development activities as we grow our business.

Loss on debt extinguishment

	Three Months Ended June 30, 2008					Three Months Ended June 30, 2007					Year-Over-Year Change
	Amount		% of net sales			Amount		% of net sales			Amount		% of change
Loss on debt extinguishment	$	1,529,000		14.9	%	$	-		0.	%	$	1,529,000		*NM

*NM= Not measureable

	Nine Months Ended June 30, 2008					Nine Months Ended June 30, 2007					Year-Over-Year Change
	Amount		% of net sales			Amount		% of net sales			Amount		% of change
Loss on debt extinguishment	$	3,996,000		21.5	%	$	-		0.	%	$	3,996,000		*NM

*NM= Not measureable

For the three months ended June 30, 2008, we incurred a loss on debt extinguishment of $1.5 million. During the quarter, part of our Series A and B convertible notes were converted into common stock which resulted in the non-cash loss of $1.5 million.

For the nine months ended June 30, 2008, we incurred a loss on debt extinguishment of $4.0 million. That loss was the result of a loss of $4.4 million related to converting Series A and B convertible notes into common stocks. The loss was partially offset by a gain of $0.4 million on settlement of loan due to Coach Capital LLC and Infotech Essentials Ltd.

Other income (expense)

	Three Months Ended June 30, 2008						Three Months Ended June 30, 2007						Year-Over-Year Change
	Amount			% of net sales			Amount			% of net sales			Amount			% of change
Interest income	$	24,000			0.2	%	$	27,000			1.8	%	$	(3,000	)		(11.1	)%
Interest expense		(238,000	)		(2.3	)%		(280,000	)		(18.5	)%		42,000			(15.	)%
Gain (loss) on change in fair market value of compound embedded derivative		(22,000	)		(0.2	)%		7,100,000			468.	%		(7,122,000	)		(100.3	)%
Gain (loss) on change in fair market value of warrant liability		107,000			1.	%		4,532,000			298.7	%		(4,425,000	)		(97.6	)%
Other expense		(107,000	)		(1.	)%		(267,000	)		(17.6	)%		160,000			(59.9	)%
Total other income (expense)	$	(236,000	)		(2.3	)%	$	11,112,000			732.5	%	$	(11,348,000	)		(102.1	)%

	Nine Months Ended June 30, 2008						Nine Months Ended June 30, 2007						Year-Over-Year Change
	Amount			% of net sales			Amount			% of net sales			Amount			% of change
Interest income	$	80,000			0.4	%	$	40,000			2.6	%	$	40,000			100.	%
Interest expense		(814,000	)		(4.4	)%		(334,000	)		(22.	)%		(480,000	)		143.7	%
Loss on issuance of convertible notes		-			0.	%		(15,209,000	)		(1,000.6	)%		15,209,000			*NM
Gain (loss) on change in fair market value of compound embedded derivative		12,267,000			66.	%		(5,500,000	)		(361.8	)%		17,767,000			(323.	)%
Gain (loss) on change in fair market value of warrant liability		11,030,000			59.4	%		(5,427,000	)		(357.	)%		16,457,000			(303.2	)%
Other expense		(435,000	)		(2.3	)%		(267,000	)		(17.6	)%		(168,000	)		62.9	%
Total other income (expense)	$	22,128,000			119.1	%	$	(26,697,000	)		(1,756.4	)%	$	48,825,000			(182.9	)%

*NM= Not measureable

For the three months ended June 30, 2008, total other expense was $0.2 million, representing a decrease of $11.3 million compared to the same period of the prior year. We incurred interest expenses of $0.2 million and $0.3 million in the three months ended June 30, 2008 and 2007, respectively primarily related to the 6% interest charges on Series A and B convertible notes. In the three months ended June 30, 2008, we recorded a loss on a change in fair market value of a compound embedded derivative of $22,000 and a gain on change in the fair market value of warrant liability of $0.1 million. This compared to a gain on a change in the fair market value of a compound embedded derivative of $7.1 million and a gain on change in fair market value of warrant liability of $4.5 million during the three months ended June 30, 2007. Other expense of $0.1 million in the three months ended June 30, 2008 was primarily related to foreign exchange loss resulting from unfavorable movements in foreign exchange rates.

For the nine months ended June 30, 2008, total other income was $22.1 million, representing an increase of $48.8 million or 182.9% from other expense of $26.7 million in the nine months ended June 30, 2007. In the nine months ended June 30, 2008, we recorded a gain on a change in fair market value of a compound embedded derivative of $12.3 million and a gain on change in fair market value of warrant liability of $11.0 million compared to a loss on change in fair market value of compound embedded derivative of $5.5 million and a loss on change in fair market value of warrant liability of $5.4 million during the nine months ended June 30, 2007. We incurred interest expenses of $0.8 million and $0.3 million in the nine months ended June 30, 2008 and 2007, respectively, primarily related to 6% interest charges on Series A and B convertible notes. Other expense of $0.4 million in the nine months ended June 30, 2008 was primarily related to foreign exchange loss resulting from unfavorable movements in foreign exchange rates.

Liquidity and Capital Resources

		June 30, 2008			September 30, 2007			Change
Cash and cash equivalents		$	2,681,000		$	3,908,000		$	(1,227,000	)

As of June 30, 2008, we had cash and cash equivalents of $2.7 million, as compared to $3.9 million at September 30, 2007. We funded our operations mainly from private sales of equity securities and loans. We believe that we currently have sufficient working capital to fund our current operations (one production line) for the next twelve months. Changes in our operating plans, an increase in our inventory, increased expenses, additional acquisitions, or other events, may cause us to seek additional equity or debt financing in the future.

	Nine Months Ended June 30,
	2008			2007

Net cash provided by (used in):

Operating activities	$	(14,140,000	)	$	(6,670,000	)

Investing activities		(6,846,000	)		(2,283,000	)

Financing activities		19,887,000			17,139,000

Effect of exchange rate changes on cash and cash equivalents		(128,000	)		84,000

Net decrease in cash and cash equivalents	$	(1,227,000	)	$	8,270,000

Net cash used in operating activities were $14.1 million and $6.7 million for the nine months ended June 30, 2008 and 2007, respectively. The increase of $7.4 million was mainly used to support the daily operations and expand the company’s selling, marketing and general and administrative functions. The increased of net cash used in operating activities resulted from $2.7 million of lower non-cash items adjustments mainly from gain on change in fair market value of warrant liability, gain on change in fair market value of compound embedded derivatives, loss on issuance of convertible notes and stock-based compensation expense, partially offset by higher net income. In addition, the increase of net cash used in operating activities was attributable to the changes in operating assets and liabilities of $4.7 million, mainly from higher accounts receivable, higher VAT taxes receivable and lower accounts payable related to inventory purchases, partially offset by lower advanced payment for raw material at June 30, 2008.

Net cash used in investment activities were $6.8 million and $2.3 million for the nine months ended June 30, 2008 and 2007, respectively. The increase of $4.5 million in investing activities was due to increased investment in our manufacturing facility and production line in Shanghai, China.

Net cash provided by financing activities totaled $19.9 million and $17.1 million for the nine months ended June 30, 2008 and 2007, respectively. The increase of $2.8 million was mainly due to proceeds of $19.9 million in January 2008 from issuing common stock and warrants, net of financing cost through private equity financing. That compares to proceeds of $17.0 million received in March 2007 from issuing convertible notes and warrants, net of deferred acquisition costs through private equity financing.

The exchange rate changes on cash and cash equivalents were primarily from exchange gains of balances held in Chinese Renminbi (RMB). The exchange rates at June 30, 2008 and 2007 were 1 U.S. dollar for RMB 6.8591 and 1 U.S. dollar for RMB 7.6155, respectively.

Our current cash requirements are significant because, aside from our operational expenses, we are building our inventory of silicon wafers as we ramp-up our production capability. We are also constructing a second production line, which we expect to complete in calendar year 2008. The cost of silicon wafers, which is the primary cost of sales for our SolarE solar modules, is currently volatile and is expected to rise due to a current supply shortage. We are uncertain of the extent to which this will negatively affect our working capital in the near future. A significant increase in the cost of silicon wafers that we cannot pass on to our customers could cause us to run out of cash more quickly than our projections, requiring us to raise additional funds or curtail operations.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a Smaller Reporting Company as defined Rule 12b-2 of the Exchange Act and in item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item 3.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Management carried out an evaluation, under the supervision and with the participation of our President and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. The evaluation was undertaken in consultation with our accounting personnel. Based on that evaluation, the President and Chief Financial Officer concluded that our disclosure controls and procedures are not effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms because of the existence of a material weakness related to inadequate control over accounting and reporting for certain non-routine transactions. During the process of preparing the fiscal year 2007 Form 10-KSB, management was incorrect in calculating the withholding tax liability associated with stock options exercised by the President and CEO of the Company. We restated our consolidated financial statements for the fiscal year ended September 30, 2006 and subsequent quarters ended June 30, 2007, March 31, 2007 and December 31, 2006 in order to properly reflect additional accrued liability.

We have taken the following steps to correct this weakness:

•

In October 2007, we added a financial controller to oversee our Chinese operations;

•

During the quarter ended December 31, 2007, we began training of our accounting staff on generally accepted accounting principles in the United States (“U.S. GAAP”);

•

During the quarter ended June 30, 2008, we completed implementation of our Enterprise Resource Planning system to improve the reporting and business performance . The system is used by all key departments in all locations in China; and

•

Throughout the fiscal year 2008, we engaged a third party consultant with the requisite expertise to assist with analysis and accounting for non-routine transactions.

Internal Control Over Financial Reporting

Except as discussed above, our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has concluded there were no changes in our internal controls over financial reporting that occurred during the fiscal quarter ended June 30, 2008 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 4T. CONTROLS AND PROCEDURES

Reference is made to the disclosures above in Item 4. Controls and Procedures.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None

ITEM 1A. RISK FACTORS

There have been no material changes in our risk factors from those disclosed in our 2007 Annual Report on Form 10-K SB.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

At our annual meeting of stockholders on May 5, 2008, the stockholders elected each of the nominees for directors to our Board of Directors. The votes were as follows:

Nominee	For		Withheld
Leo Shi Young		79,783,081		721,606
Shi Jian Yin		75,775,671		729,016
Kevin Koy		79,773,622		731,065
Robert Coackley		79,780,699		723,988
Donald Morgan		79,782,989		781,698

The following matters were also submitted to and approved by a vote of the stockholders with the results of the voting being as shown:

Ratification of the Appointment of Ernst & Young Hua Ming

	Shares
For approval		79,400,457
Against approval		281,787
Abstained		822,443

Amendment and Restatement of 2007 Equity Incentive Plan

	Shares
For approval		62,261,251
Against approval		1,126,607
Abstained		347,552
Broker Non-Votes		16,796,277

Reincorporation into the State of Delaware

	Shares
For approval		63,412,123
Against approval		202,101
Abstained		121,186
Broker Non-Votes		16,769,277

Approve an Increase of the Company’s Authorized Shares of Common Stock

	Shares
For approval		72,938,280
Against approval		5,528,053
Abstained		538,354

Approve any Adjournments of the Meeting to another time and place

	Shares
For approval		77,182,379
Against approval		2,105,252
Abstained		1,217,056

ITEM 5. OTHER INFORMATION

None

ITEM 6. EXHIBITS

(a) Pursuant to Rule 601 of Regulation S-K, the following exhibits are included herein or incorporated by reference.

3.1		Certificate of Incorporation, Incorporated by reference from Exhibit 3.1 to our Form 8-K filed on August 14, 2008.

3.2		By-laws, Incorporated by reference from Exhibit 3.2 to our Form 8-K filed on August 14, 2008.

3.3		Agreement and Plan of Merger with Solar EnerTech Corp., a Nevada corporation and our predecessor in interest, dated August 13, 2008, incorporated by reference from Exhibit 2.1 to our Form 8-K filed on August 14, 2008.

31.1		Section 302 Certification - Chief Executive Officer*

31.2		Section 302 Certification - Chief Financial Officer*

32.1		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Executive Officer.*

32.2		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 - Chief Financial Officer.*

* Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SOLAR ENERTECH CORP.

Date: August 14, 2008	By:	/s/ Anthea Chung

		Anthea Chung
		Chief Financial Officer

Grafico Azioni Solar Enertech (CE) (USOTC:SOEN)
Storico
Da Mag 2024 a Giu 2024

Clicca qui per i Grafici di Solar Enertech (CE)

Grafico Azioni Solar Enertech (CE) (USOTC:SOEN)
Storico
Da Giu 2023 a Giu 2024

SOEN Solar Enertech Corp (CE)

Notizie Solar Enertech Corp - SOEN

La tua Cronologia

Più Attivi

Toplist

SOEN Solar Enertech Corp (CE)

Notizie Solar Enertech Corp - SOEN

La tua Cronologia